Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw

Kim, Hye-Won; Kim, Chul‐Hwan; Kim, Ji-Kwan; Kim, Moon-Young

doi:10.1016/j.omsc.2020.100178

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Complex surgical approaches are frequently required for more severe cases [ 40 ]. Platelet-rich plasma concentrates (PRPs) [ 41 , 42 ] and recombinant human parathyroid hormone (Teriparatide) [ 43 ] are gaining attention as an adjunctive treatment in MRONJ management and prevention, by enhancing angiogenesis and osteoanabolic properties, among other effects.…”

Section: Introductionmentioning

confidence: 99%

Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review

Anitua,

Alkhraisat,

Eguia

2024

Cureus

View full text Add to dashboard Cite

There is a lack of consensus on managing resultant bone and soft tissue defects or on restoring oral function and aesthetics following medication-related osteonecrosis of the jaws (MRONJ) lesion healing. This clinical challenge presents a dilemma for practitioners. Removable prostheses pose a recurrence risk if poorly fitted and may inadequately restore function or aesthetics in cases of significant bone defect. Dental implant-supported prostheses could enhance function and quality of life, though their risks and indications are not well-defined. This systematic review examines the clinical outcomes and complications associated with implant-supported rehabilitations post-MRONJ surgery. This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement recommendations and it was pre-registered in the Prospective Register of Systematic Reviews (PROSPERO) (CRD42023492539).

show abstract